Analysis of Evusheld Safety and Efficacy in Multiple Sclerosis Patients

EN Liu, M Real, JH Yang, A Fair, N Whitmire… - Multiple Sclerosis and …, 2024 - Elsevier
ABSTRACT Background In December 2021, the US Food and Drug Administration issued
emergency use authorization for the combination monoclonal antibodies tixagevimab and …
相关文章

Analysis of Evusheld Safety and Efficacy in Multiple Sclerosis Patients

EN Liu, M Real, JH Yang, A Fair, N Whitmire… - Multiple Sclerosis and … - msard-journal.com
ABSTRACT Background In December 2021, the US Food and Drug Administration issued
emergency use authorization for the combination monoclonal antibodies tixagevimab and …